Weber BL - Search Results

1

Germline CHEK2*1100delC mutations in breast cancer patients with multiple primary cancers.

Huang J, Domchek SM, Brose MS, Rebbeck TR, Nathanson KL, Weber BL. Huang J, et al. Among authors: weber bl. J Med Genet. 2004 Nov;41(11):e120. doi: 10.1136/jmg.2004.022913. J Med Genet. 2004. PMID: 15520402 Free PMC article. No abstract available.

2

Polymorphisms in PTEN in breast cancer families.

Carroll BT, Couch FJ, Rebbeck TR, Weber BL. Carroll BT, et al. Among authors: weber bl. J Med Genet. 1999 Feb;36(2):94-6. J Med Genet. 1999. PMID: 10051004 Free PMC article.

3

BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers.

Shih HA, Nathanson KL, Seal S, Collins N, Stratton MR, Rebbeck TR, Weber BL. Shih HA, et al. Among authors: weber bl. Clin Cancer Res. 2000 Nov;6(11):4259-64. Clin Cancer Res. 2000. PMID: 11106241

4

"Other" breast cancer susceptibility genes: searching for more holy grail.

Nathanson KL, Weber BL. Nathanson KL, et al. Among authors: weber bl. Hum Mol Genet. 2001 Apr;10(7):715-20. doi: 10.1093/hmg/10.7.715. Hum Mol Genet. 2001. PMID: 11257104 Review.

5

Absence of BRAF mutations in UV-protected mucosal melanomas.

Edwards RH, Ward MR, Wu H, Medina CA, Brose MS, Volpe P, Nussen-Lee S, Haupt HM, Martin AM, Herlyn M, Lessin SR, Weber BL. Edwards RH, et al. Among authors: weber bl. J Med Genet. 2004 Apr;41(4):270-2. doi: 10.1136/jmg.2003.016667. J Med Genet. 2004. PMID: 15060100 Free PMC article.

6

BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic.

Shih HA, Couch FJ, Nathanson KL, Blackwood MA, Rebbeck TR, Armstrong KA, Calzone K, Stopfer J, Seal S, Stratton MR, Weber BL. Shih HA, et al. Among authors: weber bl. J Clin Oncol. 2002 Feb 15;20(4):994-9. doi: 10.1200/JCO.2002.20.4.994. J Clin Oncol. 2002. PMID: 11844822

7

CGH-targeted linkage analysis reveals a possible BRCA1 modifier locus on chromosome 5q.

Nathanson KL, Shugart YY, Omaruddin R, Szabo C, Goldgar D, Rebbeck TR, Weber BL. Nathanson KL, et al. Among authors: weber bl. Hum Mol Genet. 2002 May 15;11(11):1327-32. doi: 10.1093/hmg/11.11.1327. Hum Mol Genet. 2002. PMID: 12019214

8

Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.

Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL. Brose MS, et al. Among authors: weber bl. J Natl Cancer Inst. 2002 Sep 18;94(18):1365-72. doi: 10.1093/jnci/94.18.1365. J Natl Cancer Inst. 2002. PMID: 12237282

9

Application of breast cancer risk prediction models in clinical practice.

Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL. Domchek SM, et al. Among authors: weber bl. J Clin Oncol. 2003 Feb 15;21(4):593-601. doi: 10.1200/JCO.2003.07.007. J Clin Oncol. 2003. PMID: 12586794 Review.

10

Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility.

Schutte M, Seal S, Barfoot R, Meijers-Heijboer H, Wasielewski M, Evans DG, Eccles D, Meijers C, Lohman F, Klijn J, van den Ouweland A, Futreal PA, Nathanson KL, Weber BL, Easton DF, Stratton MR, Rahman N; Breast Cancer Linkage Consortium. Schutte M, et al. Among authors: weber bl. Am J Hum Genet. 2003 Apr;72(4):1023-8. doi: 10.1086/373965. Epub 2003 Feb 27. Am J Hum Genet. 2003. PMID: 12610780 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

226 results

Search Page